Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years

Authors

John E Harris
Amit G Pandya
Mark Lebwohl
Iltefat H. Hamzavi, Henry Ford HealthFollow
Pearl Grimes
Alice B Gottlieb
Howard L Sofen
Angela Y Moore
Mingyue Wang
Deanna Kornacki
Kathleen Butler
David Rosmarin

Recommended Citation

Harris JE, Pandya AG, Lebwohl M, Hamzavi IH, Grimes P, Gottlieb AB, Sofen HL, Moore AY, Wang M, Kornacki D, Butler K, and Rosmarin D. Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years. Skin Health Dis 2024; 4(6):e404.

Document Type

Article

Publication Date

12-1-2024

Publication Title

Skin Health Dis

PubMed ID

39624731

Volume

4

Issue

6

First Page

404

Last Page

404